Safety and efficacy of the anti-α-synuclein

lzliuzhuo_ylyy

题名	Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial
链接	https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00100-6/abstract

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00100-6/abstract